Michael Gladstone

Insider Reports History

Entity
Individual
Location
395 Oyster Point Blvd, Suite 217, South San Francisco, California
Signature
/s/ Christopher Murphy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Gladstone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Day One Biopharmaceuticals, Inc. Director Director Stock Option (Right to buy Common Stock) 37.5K Jun 22, 2023 Direct
Day One Biopharmaceuticals, Inc. Director Stock Option (right to buy Common Stock) 32.3K May 23, 2024 Direct
Third Harmonic Bio, Inc. Director, 10%+ Owner Director Stock Option (right to buy) 20K Jun 6, 2024 Direct

Insider Reports Filed by Michael Gladstone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
THRD Third Harmonic Bio, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director, 10%+ Owner
DAWN Day One Biopharmaceuticals, Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
DAWN Day One Biopharmaceuticals, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
THRD Third Harmonic Bio, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
THRD Third Harmonic Bio, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
THRD Third Harmonic Bio, Inc. Oct 26, 2022 1 $0 4 Oct 27, 2022 Director
THRD Third Harmonic Bio, Inc. Sep 14, 2022 0 $0 3 Sep 14, 2022 Director
DAWN Day One Biopharmaceuticals, Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
DAWN Day One Biopharmaceuticals, Inc. Jun 17, 2022 1 $11.5M 4 Jun 22, 2022 Director
DAWN Day One Biopharmaceuticals, Inc. May 26, 2021 0 $0 3 May 26, 2021 Director